Sinomed Neurovita Technology Inc.
6
0
0
4
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
16.7%
1 terminated/withdrawn out of 6 trials
80.0%
-6.5% vs industry average
0%
0 trials in Phase 3/4
25%
1 of 4 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (6)
Compare the Safety and Effectiveness of Two Different Kinds of Stent System in Intracranial Aneurysms
Role: lead
Safety and Efficacy of SINOMED SR for Endovascular Treatment of Acute Ischemic Stroke
Role: lead
Parent Artery Reconstruction for Cerebral Aneurysms Using a Novel Flow Diverter With Surface Modification
Role: lead
Efficacy and Safety of a New Balloon Microcatheter in the Treatment of Intracranial Artery Stenosis
Role: lead
The Efficacy and Safety of Intracranial Self-expanding DES in Symptomatic Intracranial Atherosclerotic Disease
Role: lead
Safety and Efficacy of Intracranial Thrombus Aspiration Catheter in the Treatment of Acute Large-vessel Occlusive Stroke
Role: lead
All 6 trials loaded